Alok A. Khorana, MD

Alok Khorana, MD, discusses increasing rates of young-onset pancreatobiliary adenocarcinoma.

Alok A. Khorana, MD, professor of Medicine, Department of Hematology and Oncology, Cleveland Clinic, discusses a study that examined practice patterns and patient persistence on anticoagulant treatments for cancer-associated thrombosis.

Alok Khorana, MD, medical oncologist, Cleveland Clinic, discusses blood clot risk and treatment for patients with cancer.

The movement towards digitization is being driven by regulatory and governmental authorities, with the aim to increase accessibility to information, reduce errors, and improve compliance with quality and performance measures.

It seems that every year, the list of Accreditation Council for Graduate Medical Education (ACGME) requirements grows longer and more bewildering.

Cancer-associated thrombosis occurs commonly in patients with cancer, particularly during treatment with anticancer therapies.